$CCRN

FITZGERALD GALE S sold (to issuer) $1.5M of CCRN

FITZGERALD GALE S sold (to issuer) 114,331 shares of CROSS COUNTRY HEALTHCARE INC (CCRN) at $13.25 ($1.51M total) on 2026-07-21.

Original reporting
SEC EDGAR · FITZGERALD GALE S
Published Jul 21, 2026, 8:10 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 21, 2026, 8:11 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$CCRN
Neutral
high confidence
Mentioned
$CCRN
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CCRNNeutralLow
01

Why it matters

The disclosed fact is the director’s sale size, price, and post-transaction holdings (0 shares). No new guidance, contract, or regulatory event is mentioned.

02

Market read

Traders may note the director fully exited, but the transaction is to the issuer and lacks a fundamental catalyst in the text.

03

What to watch

The filing does not state the director’s rationale, and the absence of a 10b5-1 plan does not, by itself, imply unusual information.

Relevance 6/10Novelty 2/10Timing: Filed 2026-07-21, after-hours SEC Form 4 disclosure

Background

The article is an SEC Form 4 insider transaction disclosure for Cross Country Healthcare.

Company-level read

Ticker impact

$CCRNNeutralHigh confidence
Context

Cross Country Healthcare director Fitzgerald sold 114,331 shares to the issuer for $13.25/share, leaving 0 shares after the transaction.

Expected impact

Limited near-term impact; any effect is likely sentiment-only unless paired with other disclosures.

Evidence & confidence

Form 4 shows a director sale with no 10b5-1 plan and no accompanying company-specific catalyst in the filing text.

Market effects

None indicated; this is company-specific insider transaction data.

None indicated.

None indicated.

Counterpoint

Because the sale is to the issuer, it may reflect mechanical buyback participation rather than a bearish view on fundamentals.

Key entities

  • CROSS COUNTRY HEALTHCARE INC

    Subject of the Form 4 insider transaction disclosure.

  • FITZGERALD GALE S

    Director who sold 114,331 shares to the issuer at $13.25/share.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LWAYLow

Divisadero Street Capital Management, LP (Zolezzi William) purchased $6.1M of LWAY (indirect holdings)

Divisadero Street Capital Management, LP purchased 246,568 indirectly-held shares of Lifeway Foods, Inc. (LWAY) at an average of $24.85 ($24.69–$24.87, $6.13M total) across 3 trades over 2026-08-13 to 2026-08-17. Filed jointly with Divisadero Street Partners GP, LLC (10% owner), Divisadero Street Capital, LLC (10% owner), Divisadero Street Partners, L.P. (10% owner) and Zolezzi William (10% owner).